ArticleOxford medical case reports2025
Aggressive management and liver transplantation in Budd-Chiari syndrome secondary to Behçet's disease.
Article in Oxford medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Budd-Chiari Syndrome (BCS) is a rare vascular disorder caused by hepatic venous outflow obstruction, often due to thrombosis, leading to liver congestion and portal hypertension. Behçet's Disease (BD), a chronic vasculitis, can cause BCS through inflammation-induced thrombosis. We report a 14-year-old male with BD who developed BCS. He initially presented with foot pain, uveitis, and a bilateral rash, later progressing to abdominal distension, jaundice, and hepatic dysfunction. Investigations revealed elevated transaminases and hyperbilirubinemia, with imaging confirming hepatic vein thrombosis. Management included corticosteroids, immunosuppressants, and anticoagulation. Despite treatment, liver function deteriorated, necessitating a transplant, after which he stabilized with significant symptomatic improvement. This case underscores the need for early recognition of BD-related vascular complications, timely intervention to prevent irreversible liver damage, and consideration of liver transplantation in severe BCS. Increased awareness of BD as a potential cause of BCS is crucial for prompt diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.